Phase 2 Trial of Pertuzumab and Trastuzumab With Weekly Paclitaxel and Chemotherapy for HER2 Positive Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Her2-Positive Breast Cancer
Interventions: DRUG: Pertuzumab|DRUG: Trastuzumab|DRUG: Paclitaxel|DRUG: 5-fluorouracil|DRUG: Epirubicin|DRUG: Cyclophosphamide
Sponsor: Yale University
Collaborators: Genentech, Inc.